UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Chronic lymphocytic leukaemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Annals of oncology, 2021-01, Vol.32 (1), p.23-33

2021

Volltextzugriff (PDF)

Myelodysplastic syndromes: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Annals of oncology, 2021-02, Vol.32 (2), p.142-156

2021

Volltextzugriff (PDF)

Multiple myeloma: EHA-ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Annals of oncology, 2021-03, Vol.32 (3), p.309-322

2021

Volltextzugriff (PDF)

Impact of individualized treatment on recovery from fatigue and return to work in survivors of advanced-stage Hodgkin’s lymphoma: results from the randomized international GHSG HD18 trial

Annals of oncology, 2024-03, Vol.35 (3), p.276-284

2024

Volltextzugriff (PDF)

Corrigendum to “Corrigendum to ‘Multiple myeloma: EHA-ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up’”

Annals of oncology, 2022-09, Vol.33 (9), p.988-988

2022

Volltextzugriff (PDF)

Corrigendum to ‘Multiple myeloma: EHA-ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up’: [Ann Oncol 2021; 32(3): 309-322]

Annals of oncology, 2022-01, Vol.33 (1), p.117-117

2022

Volltextzugriff (PDF)

SAKK 38/19: ASSESSING A CTDNA AND PET‐ORIENTED THERAPY IN PATIENTS WITH DLBCL. A MULTICENTER, OPEN‐LABEL, PHASE II TRIAL

Hematological oncology, 2023-06, Vol.41 (S2), p.165-166

2023

Volltextzugriff (PDF)

Nelfinavir and lenalidomide/dexamethasone in patients with lenalidomide-refractory multiple myeloma. A phase I/II Trial (SAKK 39/10)

Blood cancer journal (New York), 2019-08, Vol.9 (9), p.70-8, Article 70

2019

Volltextzugriff (PDF)

Impact of PET‐2 guided treatment de‐escalation on time‐to‐recovery from cancer‐related fatigue in advanced stage Hodgkin Lymphoma: results from the GHSG HD18 study

Hematological oncology, 2023-06, Vol.41 (S2), p.355-356

2023

Volltextzugriff (PDF)

Clinical characteristics and outcome of patients over 60 years with Hodgkin lymphoma treated in Switzerland

Hematological oncology, 2021-04, Vol.39 (2), p.196-204

2021

Volltextzugriff (PDF)

PROGNOSTIC FACTORS IN ELDERLY PATIENTS WITH CLASSICAL HODGKIN LYMPHOMA ‐ A JOINT ANALYSIS OF TWO CLINICAL DATABASES

Hematological oncology, 2021-06, Vol.39 (S2)

2021

Volltextzugriff (PDF)

Hairy cell leukemia: short review, today’s recommendations and outlook

Blood cancer journal (New York), 2014-02, Vol.4 (2), p.e184-e184

2014

Volltextzugriff (PDF)

SAKK 36/13 ‐ IBRUTINIB PLUS BORTEZOMIB AND IBRUTINIB MAINTENANCE FOR RELAPSED AND REFRACTORY MANTLE CELL LYMPHOMA: FINAL REPORT OF A PHASE I/II TRIAL OF THE EUROPEAN MCL NETWORK

Hematological oncology, 2021-06, Vol.39 (S2)

2021

Volltextzugriff (PDF)

Prognostic value of CA 19-9 levels in patients with inoperable adenocarcinoma of the pancreas treated with gemcitabine

British journal of cancer, 2003-10, Vol.89 (8), p.1413-1417

2003

Volltextzugriff (PDF)

Rituximab, bendamustine, and lenalidomide in patients with aggressive B cell lymphoma not eligible for high-dose chemotherapy or anthracycline-based therapy: phase I results of the SAKK 38/08 trial

Annals of hematology, 2013-08, Vol.92 (8), p.1033-1040

2013

Volltextzugriff (PDF)

CLINICAL CHARACTERISTICS AND OUTCOME OF PATIENTS WITH HODGKIN'S LYMPHOMA OLDER THAN 60 YEARS TREATED IN SWITZERLAND OVER THE LAST 17 YEARS

Hematological oncology, 2019-06, Vol.37 (S2), p.289-290

2019

Volltextzugriff (PDF)

SAKK 35/15: A PHASE I TRIAL OF OBINUTUZUMAB IN COMBINATION WITH VENETOCLAX IN PREVIOUSLY UNTREATED FOLLICULAR LYMPHOMA PATIENTS

Hematological oncology, 2019-06, Vol.37 (S2), p.118-119

2019

Volltextzugriff (PDF)

Sequential Hodgkin’s and non-Hodgkin’s lymphoma in non-immunocompromised patients

Annals of hematology, 2013-11, Vol.92 (11), p.1565-1567

2013

Volltextzugriff (PDF)

Evaluation of an ultrasound-guided technique for central venous access via the internal jugular vein in 493 patients

Supportive care in cancer, 2003-03, Vol.11 (3), p.148-155

2003

Volltextzugriff (PDF)

Atypical BCR-ABL mRNA transcripts in adult Acute lymphoblastic leukemia

Haematologica (Roma), 2007-12, Vol.92 (12), p.1699-1702

2007

Volltextzugriff (PDF)

Advances in the treatment of hairy-cell leukaemia

The lancet oncology, 2003-02, Vol.4 (2), p.86-94

2003

Volltextzugriff (PDF)

P6 Results from a pilot study of a brief Cancer-Specific Geriatric Assessment (CGA) tool for use in clinical trials of older cancer patients

Critical reviews in oncology/hematology, 2009, Vol.72 (1), p.S20-S21

2009

Volltextzugriff (PDF)

Mediastinale Lymphknotentuberkulose, reaktiviert unter immunsuppressiver Therapie

Deutsche medizinische Wochenschrift, 2006-02, Vol.131 (8), p.387-388

2006

Volltextzugriff (PDF)

Treatment with the HIV protease inhibitor nelfinavir triggers the unfolded protein response and may overcome proteasome inhibitor resistance of multiple myeloma in combination with bortezomib: a phase I trial (SAKK 65/08)

Haematologica (Roma), 2016-03, Vol.101 (3), p.346-355

2016

Volltextzugriff (PDF)

1 – 25 von 325

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(168)
Mit Volltextzugriff
(246)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(117)
Science & Technology
(90)
Life Sciences & Biomedicine
(84)
Male
(57)
Adult
(50)
Female
(47)
Middle Aged
(41)
Aged
(38)
Biological And Medical Sciences
(35)
Medical Sciences
(32)
Animals
(26)
Oncology
(26)
Treatment Outcome
(18)
Hematology
(17)
Aged, 80 And Over
(16)
Pharmacology. Drug Treatments
(16)
Pharmacology & Pharmacy
(15)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(14)
Lymphoma
(11)
Adolescent
(10)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(3)
... seit 90 Tagen
(6)

Menü

Weitere Dienste

Einstellungen

Chronic lymphocytic leukaemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Myelodysplastic syndromes: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Multiple myeloma: EHA-ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

ESMO Consensus Conference on malignant lymphoma: general perspectives and recommendations for the clinical management of the elderly patient with malignant lymphoma

Impact of individualized treatment on recovery from fatigue and return to work in survivors of advanced-stage Hodgkin’s lymphoma: results from the randomized international GHSG HD18 trial

Corrigendum to “Corrigendum to ‘Multiple myeloma: EHA-ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up’”

Corrigendum to ‘Multiple myeloma: EHA-ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up’: [Ann Oncol 2021; 32(3): 309-322]

SAKK 38/19: ASSESSING A CTDNA AND PET‐ORIENTED THERAPY IN PATIENTS WITH DLBCL. A MULTICENTER, OPEN‐LABEL, PHASE II TRIAL

Nelfinavir and lenalidomide/dexamethasone in patients with lenalidomide-refractory multiple myeloma. A phase I/II Trial (SAKK 39/10)

Impact of PET‐2 guided treatment de‐escalation on time‐to‐recovery from cancer‐related fatigue in advanced stage Hodgkin Lymphoma: results from the GHSG HD18 study

Clinical characteristics and outcome of patients over 60 years with Hodgkin lymphoma treated in Switzerland

PROGNOSTIC FACTORS IN ELDERLY PATIENTS WITH CLASSICAL HODGKIN LYMPHOMA ‐ A JOINT ANALYSIS OF TWO CLINICAL DATABASES

Hairy cell leukemia: short review, today’s recommendations and outlook

SAKK 36/13 ‐ IBRUTINIB PLUS BORTEZOMIB AND IBRUTINIB MAINTENANCE FOR RELAPSED AND REFRACTORY MANTLE CELL LYMPHOMA: FINAL REPORT OF A PHASE I/II TRIAL OF THE EUROPEAN MCL NETWORK

Prognostic value of CA 19-9 levels in patients with inoperable adenocarcinoma of the pancreas treated with gemcitabine

Rituximab, bendamustine, and lenalidomide in patients with aggressive B cell lymphoma not eligible for high-dose chemotherapy or anthracycline-based therapy: phase I results of the SAKK 38/08 trial

CLINICAL CHARACTERISTICS AND OUTCOME OF PATIENTS WITH HODGKIN'S LYMPHOMA OLDER THAN 60 YEARS TREATED IN SWITZERLAND OVER THE LAST 17 YEARS

SAKK 35/15: A PHASE I TRIAL OF OBINUTUZUMAB IN COMBINATION WITH VENETOCLAX IN PREVIOUSLY UNTREATED FOLLICULAR LYMPHOMA PATIENTS

Sequential Hodgkin’s and non-Hodgkin’s lymphoma in non-immunocompromised patients

Evaluation of an ultrasound-guided technique for central venous access via the internal jugular vein in 493 patients

Atypical BCR-ABL mRNA transcripts in adult Acute lymphoblastic leukemia

Advances in the treatment of hairy-cell leukaemia

P6 Results from a pilot study of a brief Cancer-Specific Geriatric Assessment (CGA) tool for use in clinical trials of older cancer patients

Mediastinale Lymphknotentuberkulose, reaktiviert unter immunsuppressiver Therapie

Treatment with the HIV protease inhibitor nelfinavir triggers the unfolded protein response and may overcome proteasome inhibitor resistance of multiple myeloma in combination with bortezomib: a phase I trial (SAKK 65/08)

Suchergebnisse filtern